Abstract:Clinically, the conventional treatments of cancer are still often accompanied by tumor recurrence, metastasis and other poor prognosis. Nowadays, more attention has been paid to photodynamic therapy (PDT), which is regarded as an adjuvant antineoplastic strategy with superiorities in great spatiotemporal selectivity and minimal invasiveness. In addition to eliminating tumor cells via reactive oxygen species (ROS), more meaningfully, this phototherapy can trigger immunogenic cell death (ICD) that plays a vital role in photodynamic immunotherapy (PDIT). ICD-based PDIT holds some immunotherapeutic potential due to further enhanced antitumor efficacy by utilizing various combined therapies to increase ICD levels. To help the PDIT-related drugs improve pharmacokinetic properties, bioavailability and system toxicity, multifunctional nanocarriers can be reasonably designed for enhanced PDIT. In further consideration of severe hypoxia, low immunity and immune checkpoints in tumor microenvironment (TME), advanced nanotherapeutics-mediated PDIT has been extensively studied for boosting antitumor immunity by oxygen-augment, ICD-boosting, adjuvant stimulation and combined checkpoints blockade. Herein, this review will summarize different categories of nanocarriers consisting of their material type, targeting and stimuli-responsiveness. Moreover, we will focus on the latest progress of various strategies to enhance the antitumor immune effect for PDIT and elucidate their corresponding immune-activation mechanisms. Nevertheless, there are several thorny challenges in PDIT, including limited light penetration, tumor hypoxia, immune escape and the development of novel small-molecule compounds that replace immune checkpoint inhibitors (ICIs) for easy integration into nanosystems. It is hoped that these issues raised will be helpful to the preclinical study of nanotherapeutics-based PDIT, thus accelerating the transformation of PDIT to clinical practice.

Revolutionizing cancer treatment: nanotechnology-enabled photodynamic therapy and immunotherapy with advanced photosensitizers

Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy

Photodynamic immunotherapy of cancers based on nanotechnology: recent advances and future challenges

Engineered nanomaterials for synergistic photo-immunotherapy

Progress in advanced nanotherapeutics for enhanced photodynamic immunotherapy of tumor

Nanomaterials-Based Photodynamic Therapy with Combined Treatment Improves Antitumor Efficacy Through Boosting Immunogenic Cell Death

Enhancing cancer immunotherapy with photodynamic therapy and nanoparticle: making tumor microenvironment hotter to make immunotherapeutic work better

Advances in smart nanotechnology-supported photodynamic therapy for cancer

Multifunctional Nanosystems Powered Photodynamic Immunotherapy

Visualized Photodynamic Nanomaterials Activating Tumor-Associated Immune Landscape As a Next-Generation Anticancer Strategy

Nanomedicines and nanomaterials for cancer therapy: Progress, challenge and perspectives

Recent Advance in Nanomaterials for Cancer Immunotherapy

Nanotechnology-based Photoimmunological Therapies for Cancer

Nanomedicines Targeting Tumor Cells or Tumor-Associated Macrophages for Combinatorial Cancer Photodynamic Therapy and Immunotherapy: Strategies and Influencing Factors

Phototherapeutic nanoagents for cancer immunotherapy

Nanotechnologies for Enhancing Cancer Immunotherapy

Enhancing cancer immunotherapy: Nanotechnology-mediated immunotherapy overcoming immunosuppression

Emerging nanotechnological strategies to reshape tumor microenvironment for enhanced therapeutic outcomes of cancer immunotherapy.

Stable triangle: nanomedicine-based synergistic application of phototherapy and immunotherapy for tumor treatment

Catalytic nanotechnology of X-ray photodynamics for cancer treatments

Engineering a photosensitizer nanoplatform for amplified photodynamic immunotherapy <i>via</i> tumor microenvironment modulation